Reaction Details Report a problem with these data
Target
Mitogen-activated protein kinase 1
Ligand
BDBM103297
Substrate
n/a
Meas. Tech.
ChEMBL_1772222 (CHEMBL4224334)
IC50
7.0±n/a nM
Citation
Boga, SB; Alhassan, AB; Cooper, AB; Doll, R; Shih, NY; Shipps, G; Deng, Y; Zhu, H; Nan, Y; Sun, R; Zhu, L; Desai, J; Patel, M; Muppalla, K; Gao, X; Wang, J; Yao, X; Kelly, J; Gudipati, S; Paliwal, S; Tsui, HC; Wang, T; Sherborne, B; Xiao, L; Hruza, A; Buevich, A; Zhang, LK; Hesk, D; Samatar, AA; Carr, D; Long, B; Black, S; Dayananth, P; Windsor, W; Kirschmeier, P; Bishop, R Discovery of 3(S)-thiomethyl pyrrolidine ERK inhibitors for oncology. Bioorg Med Chem Lett 28:2029-2034 (2018) [PubMed] Article
More Info.:
Target
Name:
Mitogen-activated protein kinase 1
Synonyms:
ERK2 | ERT1 | Extracellular signal-regulated kinase 2 | Extracellular signal-regulated kinase 2 (ERK-2) | Extracellular signal-regulated kinase 2 (ERK2) | MAP Kinase 2/ERK2 | MAPK 2 | MAPK1 | MK01_HUMAN | Mitogen activated kinase 1 (ERK-2) | Mitogen-activated protein kinase 1 (ERK-2) | Mitogen-activated protein kinase 1 (ERK2) | Mitogen-activated protein kinase 2 | PRKM1 | PRKM2 | p42-MAPK
Type:
Ser/Thr Protein Kinase
Mol. Mass.:
41392.76
Organism:
Homo sapiens (Human)
Description:
P28482
Residue:
360
Sequence:
MAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS